ILYANG PHARMACEUTICAL (1P) financial statements, including revenue, expenses, profit, and loss
The total revenue of 007575 for the last quarter is 78.49 B KRW, and it's 24.69% lower compared to the previous quarter. The net income of Q1 24 is 2.02 B KRW.